Skip to main content

Most Popular

Axial Spondyloarthritis

Update on Axial SpA at EULAR 2022

Jun 04, 2022

This year at EULAR 2022, there were important and interesting topics in Axial Spondyloarthritis (AxSpA). These are my picks of abstracts from the conference.

Read Article
RheumNow Podcast square

EULAR 2022 Top 10 Abstracts (6.10.2022)

Jun 10, 2022

Dr. Jack Cush reviews the top abstracts from EULAR 2022  As chosen by me with the  aid of the RheumNow EULAR faculty. “Top” is relative and subjective, but my criteria for inclusion are based on impact, water cooler talk potential, innovation and social media buzz.  Speaking of social media…

Read Article
Meeting audience conference

EULAR 2022 – Day 1 Report

Jun 01, 2022

It’s good to be back into full, big meeting mode.

Read Article
Malar,rash,SLE, Lupus

Emerging Therapeutics for Lupus

Jun 06, 2022

Impressive data on novel treatment for systemic lupus erythematosus (SLE) were presented at the EULAR22 Congress.

Read Article
GRAPPA,PsA,guideline

New Updated GRAPPA Psoriatic Arthritis Recommendations

Jun 29, 2022

The GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) treatment recommendations have been updated and the 2021 evidence-based guidance is rich in treatment recommendations based on the key disease "domains" - peripheral arthritis, axial disease, enthesitis, dactyliti

Read Article
Biologic.choice.MD_.jpeg (keep)

Not All RA Drug Classes Are Created Equal

MedPage Today
Jun 16, 2022

Clear differences were apparent among the three major types of targeted medications for rheumatoid arthritis (RA) in a large European registry study.

Read Article
pso.PsA_.NPF_.jpg

Updates in Psoriatic Arthritis at EULAR 2022

Jun 01, 2022

At EULAR 2022, I look forward to key topics and presentations in psoriatic arthritis (PsA). I will be sharing the details of these studies once they are presented.

Read Article
acr_session2.jpeg

EULAR 2022 – Day 2 Report

Jun 02, 2022

A full day at EULAR with oral and poster presentations of abstracts in the morning and a plethora of scientific (review) sessions in the afternoon.  The latter covering topics like sarcoidosis, Still’s disease, fibromyalgia, back pain, sarcopenia, APS, IgG4 and imaging in vasculitis.

Read Article
heart,cv,meds, events, CVD

HCQ for RA: Not a Great Idea?

MedPage Today
Jun 28, 2022

Hydroxychloroquine (HCQ) appeared less safe from a cardiovascular standpoint than methotrexate in older patients with rheumatoid arthritis (RA), analysis of Medicare data indicated.

Read Article
woman,doctor,stress,burnout,headache,HA

Burnout Threatens the Rheumatology Workforce Conundrum

Jun 21, 2022

There is a shortage of rheumatologists in Canada and the recent 2020 Canadian Rheumatology Association (CRA) Workforce and Wellness study shows that the shortage may be compounded by rheumatologist burnout, especially among young and female physicians. 

Read Article
guidelines.recommendations.jpg

BSR Guideline for Psoriatic Arthritis - 2022 Update

Jun 06, 2022

The British Society of Rheumatology (BSR) has published their updated 2022 recommendations for the use of biologics and targeted synthetic treatments in patients iwth psoriatic arthritis (PsA).  These guidelines follow initial treatment with a single conventional systemic disease-modifying anti-r

Read Article
exhibitor.floor.ACR

EULAR 2022 – Day 4 Report

Jun 04, 2022

Bags are packed, ready to go, but wait there’s more abstracts to show.

The big news today were the “late breaking” abstracts. This is usually a favorite session of many as this is where the newest of study data often is showcased. 

Read Article
cancer search news magnify

Malignancy risk on b/tsDMARDs in patients with prior malignancy history

Jun 04, 2022

For autoimmune patients with a history of malignancy, the initiation of biologic or targeted synthetic disease modifying agents (bDMARD/tsDMARDs) may provoke concern.

Read Article
heart.jpg (keep)

CV risk factors not equal when considering magnitude of risk

What can we learn from Oral Surveillance?

The Oral Surveillance trial has almost become a household word for rheumatologists.

Read Article
refridge.crisper.storage.jpg

Modest Benefits of Diet on Arthritis

Jun 21, 2022

A EULAR taskforce systematically reviewd the literature on the effects of diet and lifestyle behaviors in rheumatic and musculoskeletal diseases (RMDs), and found little evidence suggesting dietary factors can substantially affect the outcomes in people with RMDs.

Read Article
sun.jpg

Does Sunlight Trigger Lupus?

MedPage Today
Jun 22, 2022

Whether exposure to ultraviolet (UV) radiation from the sun can cause new-onset systemic lupus erythematosus (SLE) wasn't settled by data from a large, long-running epidemiologic study, but the trends indicated that it could.

Read Article
EULAR,poster

EULAR 2022 – Day 3 Report

Jun 03, 2022

By now, those of us attending the meeting know how to find a free coffee or sprite, have found comfortable meeting nooks and know our way around (lots of sneaker mileage)!  And congrats to you virtual Rheums for mastering the multi-screen, multitask simultaneous consumption posters, tweets and or

Read Article
Gender

Time to consider gender stratification in AxSpA diagnosis and management

Jun 07, 2022

Differences across genders in many aspects related to rheumatic diseases diagnosis, phenotyping, trajectories definition and prediction of response to treatment have been overlooked.

Read Article
overcome,challenge

I Need a Nemesis

Jun 09, 2022

Your nemesis needn't be a the enemy or a demon, but should be the dragon(s) you slay and what drives you daily in becoming a better you.

Read Article
×